Cargando…

Subcellular localization of the enterobacterial common antigen GT‐E‐like glycosyltransferase, WecG

Enterobacterales have developed a specialized outer membrane polysaccharide (enterobacterial common antigen [ECA]). ECA biosynthesis begins on the cytoplasmic side of the inner membrane (IM) where glycosyltransferases sequentially add sugar moieties to form a complete repeat unit which is then trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Maczuga, Nicholas, Tran, Elizabeth N. H., Morona, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804384/
https://www.ncbi.nlm.nih.gov/pubmed/36006410
http://dx.doi.org/10.1111/mmi.14973
Descripción
Sumario:Enterobacterales have developed a specialized outer membrane polysaccharide (enterobacterial common antigen [ECA]). ECA biosynthesis begins on the cytoplasmic side of the inner membrane (IM) where glycosyltransferases sequentially add sugar moieties to form a complete repeat unit which is then translocated across the IM by WzxE before being polymerized into short linear chains by WzyE/WzzE. Research into WecG, the enzyme responsible for generating ECA lipid‐II, has not progressed beyond Barr et al. (1988) who described WecG as a membrane protein. Here we revise our understanding of WecG and re‐characterize it as a peripherally associated membrane protein. Through the use of Western immunoblotting we show that WecG in Shigella flexneri is maintained to the IM via its three C‐terminal helices and further identify key residues in helix II which are critical for this interaction which has allowed us to identify WecG as a GT‐E glycosyltransferase. We investigate the possibility of protein complexes and ultimately show that ECA lipid‐I maintains WecG to the membrane which is crucial for its function. This research is the first since Barr et al. (1988) to investigate the biochemistry of WecG and reveals possible novel drug targets to inhibit WecG and thus ECA function and cell viability.